Page last updated: 2024-10-29

imipramine and Malignant Carcinoid Syndrome

imipramine has been researched along with Malignant Carcinoid Syndrome in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Malignant Carcinoid Syndrome: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SMITH, AN1
PRESHAW, RM1
SIRCUS, W1

Other Studies

1 other study available for imipramine and Malignant Carcinoid Syndrome

ArticleYear
CLINICAL FEATURES IN PATIENTS WITH THE CARCINOID SYNDROME.
    Gastroenterology, 1965, Volume: 48

    Topics: Blood; Cardiac Catheterization; Chlorpromazine; Drug Therapy; Edema; Gastrointestinal Tract; Hydrazi

1965